GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true
In addition, injection site side effects were reported for Bydureon including local inflammation, abscess formation and cosmetic concerns due to retention of bumps under the skin that remain for extended periods of time due to the long time required for polymer degradation [159]
Not juice
These biomarkers could possibly be used to monitor and document disease progression
Leading pharmaceutical companies collaborate to improve R&D efficiency, speed up regulatory approvals, and bring new therapies to market more quickly
Dosing should always start low and increase gradually